- Appointed Dr. Jun Sik Jeoung as Senior Scientific Advisor of Commercialization & Cell Development
- Over 17 Years of Experience in Lithium-Ion Battery R&D, Scale-Up, and Production at Global Battery Cell Manufacturers & Automotive OEM
- At Samsung, Led BMW i3 EV Automotive Cell Development and Commercial Deployment
- Will Design and Manufacture NEO’s Large-Scale Batteries for Commercial Qualification & Provide Commercialization Insight for Silicon Anode Mass Production
TORONTO, May 15, 2025 (GLOBE NEWSWIRE) — NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the appointment of Dr. Jun Sik Jeoung as Senior Scientific Advisor of Commercialization & Cell Development.
With a Ph.D. in Materials Science and Engineering from the University of Arizona, Dr. Jeoung is a globally recognized R&D and commercialization expert in lithium-ion (Li-ion) battery technology with over 17 years of hands-on experience in Li-ion battery R&D, scale-up, and production technologies. Throughout his career at global automotive and battery cell manufacturers, Dr. Jeoung has led high-impact projects in Li-ion battery development, including the design, optimization, and commercial deployment of 21700 cylindrical cells, prismatic cells, and pouch cells for electric vehicle applications.
At Samsung SDI, Dr. Jeoung made a pivotal contribution by leading the development of BMW i3 EV’s 94Ah automotive cells, underscoring his ability to execute technically demanding, large-scale commercial projects. Before joining NEO, he served as Vice President of R&D at EoCell, a Silicon Valley-based silicon battery technology company. Dr. Jeoung successfully increased cell energy density and safety during his role, collaborated with Morrow Batteries (Norway’s premier giga-scale battery manufacturer) to develop commercial LFP-based EV cells, and managed global teams to deliver high-performance battery solutions.
With the escalated downstream demand for NEO’s P-300N silicon anodes and capacity expansion for mass production testing, Dr. Jeoung is a critical addition during this scale-up period, as the Company progresses towards Phase I expansion to 240 tons production. As Senior Scientific Advisor of Commercialization & Cell Development, he will (i) design and manufacture large-scale batteries for commercial material qualification and (ii) provide commercialization know-how for silicon anode manufacturing.
Dr. Jeoung commented, “Among the most practical and economical alternatives for realizing high energy density and rapid-charging capabilities of Li-ion batteries, silicon anode integration is a must in the cell design. These silicon materials should be inexpensive while sufficiently enhancing battery performance. By demonstrating high-performance Li-ion cells utilizing NEO’s silicon materials, NEO’s low-cost silicon anodes will secure the excellence of battery performance and a unique position in the market. I look forward to contributing to NEO’s successful mass production and commercial integration in the silicon anode materials market.”
Mr. Spencer Huh, President & CEO of NEO, stated, “Dr. Jeoung is a pioneer of Li-ion battery technologies focusing on high capacity, safety, quality, and energy efficiency. We are highly excited to invite Dr. Jeoung to the team during this crucial juncture of scale-up. Moreover, to ensure NEO’s continued growth and to create new strategic business, he will contribute to the technological development of high-energy density and fast-charging Li-ion batteries with NEO’s silicon anodes by utilizing his background in advanced Li-ion cell design, materials research, process optimization, and team leadership.”
In addition to Dr. Jeoung’s Li-ion battery expertise, he has experience in Plasma Display Panel (PDP) production technologies, where he led process innovations that significantly reduced defect rates and improved manufacturing yields at Samsung. Dr. Jeoung’s ability to identify and solve complex technical challenges, build collaborative partnerships, and lead cross-functional teams have been a hallmark of his career.
About NEO Battery Materials Ltd.
NEO Battery Materials is a Canadian battery materials technology company focused on developing silicon anode materials for lithium-ion batteries in electric vehicles, electronics, and energy storage systems. With a patent-protected, low-cost manufacturing process, NEO Battery enables longer-running and ultra-fast charging batteries compared to existing state-of-the-art technologies. The Company aims to be a globally-leading producer of silicon anode materials for the electric vehicle and energy storage industries. For more information, please visit the Company’s website at: https://www.neobatterymaterials.com/.
On Behalf of the Board of Directors
Spencer Huh
Director, President, and CEO
For Investor Relations, PR & More Information:
info@neobatterymaterials.com
T: +1 (437) 451-7678
This news release includes certain forward-looking statements as well as management’s objectives, strategies, beliefs and intentions. All information contained herein that is not clearly historical in nature may constitute forward-looking information. Generally, such forward-looking information can be identified notably by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: volatile stock prices; the general global markets and economic conditions; the possibility of write-downs and impairments; the risk associated with the research and development of advanced and battery-related technologies; the risk associated with the effectiveness and feasibility of technologies that have not yet been tested or proven on commercial scale; manufacturing process scale-up risks, including maintaining consistent material quality, production yields, and process reproducibility at a commercial scale; compatibility issues with existing battery chemistries and unforeseen the risks associated with entering into and maintaining collaborations, joint ventures, or partnerships with battery cell manufacturers, original equipment manufacturers, and various companies in the global battery supply chain; the risks associated with the construction, completion, and financing of commercial facilities including the Windsor and South Korean facilities; the risks associated with supply chain disruptions or cost fluctuations in raw materials, processing chemicals, and additive prices, impacting production costs and commercial viability; the risks associated with uninsurable risks arising during the course of research, development and production; competition faced by the Company in securing experienced personnel and financing; access to adequate infrastructure and resources to support battery materials research and development activities; the risks associated with changes in the technology regulatory regime governing the Company; the risks associated with the timely execution of the Company’s strategies and business plans; the risks associated with the lithium-ion battery industry’s demand and adoption of the Company’s silicon anode technology; market adoption and integration challenges, including the difficulty of incorporating silicon anodes within battery manufacturers and OEMs systems; the risks associated with the various environmental and political regulations the Company is subject to; risks related to regulatory and permitting delays; the reliance on key personnel; liquidity risks; the risk of litigation; risk management; and other risk factors as identified in the Company’s recent Financial Statements and MD&A and in recent securities filings for the Company which are available on www.sedarplus.ca. Forward-looking information is based on assumptions management believes to be reasonable at the time such statements are made, including but not limited to, continued R&D and commercialization activities, no material adverse change in precursor prices, development and commercialization plans to proceed in accordance with plans and such plans to achieve their stated expected outcomes, receipt of required regulatory approvals, and such other assumptions and factors as set out herein. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Such forward-looking information has been provided for the purpose of assisting investors in understanding the Company’s business, operations, research and development, and commercialization plans and may not be appropriate for other purposes. Accordingly, readers should not place undue reliance on forward-looking information. Forward-looking information is made as of the date of this presentation, and the Company does not undertake to update such forward-looking information except in accordance with applicable securities laws.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Lynch Carpenter Investigates Claims in Mountain Laurel Dermatology Data Breach - July 18, 2025
- Blakely McCrory Hope Fund Established at Moody Gardens to Honor Chairman’s Granddaughter After Tragic Hill Country Flooding - July 18, 2025
- Chino Commercial Bancorp Reports 25% Increase in Net Earnings - July 18, 2025
